United States: WilmerHale Reps Eleven Biotherapeutics In Acquisition Of Viventia Bio
Last Updated: September 26 2016

Eleven Biotherapeutics, Inc. and Viventia Bio Inc. announced that the two companies and the shareholders of Viventia entered into a definitive share purchase agreement under which Eleven Biotherapeutics agreed to, and simultaneously completed, the acquisition of Viventia.

The acquisition creates a NASDAQ-listed company focused on the development of novel therapies based upon antibody fragments genetically fused to cytotoxic proteins, or targeted protein therapeutics, as new treatments in areas of oncology with significant unmet need.

The WilmerHale representation was led by Partners Brian Johnson and Hal Leibowitz (M&A). The Corporate team included Partner Belinda Juran, Counsel Chris Barnstable-Brown, Senior Associate Ryan Mitteness, and Associates Claire Sarno, Colin Beauvais and John Wagner. Tax, Executive Compensation and Employee Benefits advice was provided by Partners Bill Caporizzo, Amy Null, Laura Schneider and Kimberly Wethly, and Counsel Meghan Walsh

Read the press release for more information.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Press Releases from this Firm
Recent Content from this Firm
By David Gammell
By Jonathan Cedarbaum, D. Reed Freeman, Jr., Alan Schoenfeld, Heather Zachary, Stephanie Simon
By Alan Wilson, Jonathan Wolfman
By Ambassador Charlene Barshefsky, Naboth van den Broek, David Ross, Patrick J. McLain, David Horn
By Frederick Saugman
By Bill Warren
By Michael Connor, H. David Gold, Sarah Judkins, Andrew L. Spielman
By Lester Ross, Tingting Liu
By H. David Gold, Rachel Jacobson, Heidi K. Ruckriegle
By Joseph Mueller, Thomas Saunders, Leslie Pearlson
Font Size: